Skip to main content
Log in

Bilateral Skin Ulceration after Injection of Pegylated Interferon-α-2b in a Patient with Chronic Hepatitis C

  • Case Reports
  • Published:
Clinical Drug Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Table I
Fig. 1
Fig. 2
Fig. 3

Notes

  1. 1The use of tradenames is for product identification purposes only and does not imply endorsement.

References

  1. Carithers Jr RL, Emerson SS. Therapy of hepatitis C: metaanalysis of interferon alfa-2b trials. Hepatology 1997; 26: 83S–8S

    Article  PubMed  CAS  Google Scholar 

  2. Farrell GC. Therapy of hepatitis C: interferon alfa-n1 trials. Hepatology 1997; 26: 96S–100S

    Article  PubMed  CAS  Google Scholar 

  3. Wang YS, Youngster S, Grace M, et al. Structural and biological characterization of pegylated recombinant interferon alpha-2b and its therapeutic implications. Adv Drug Deliv Rev 2002; 54: 547–70

    Article  PubMed  CAS  Google Scholar 

  4. Poynard T. Effect of pegylated interferon on liver histology. Drug Saf 2002; 2: 14–5

    Google Scholar 

  5. Charron A, Bessis D, Dereure O, et al. Local cutaneous side effects of interferons. Presse Med 2001; 30: 1555–60

    PubMed  CAS  Google Scholar 

  6. Hadziyannis SJ. Skin diseases associated with hepatitis C virus IFNection. J Eur Acad Dermatol Venereol 1998; 10: 12–21

    Article  PubMed  CAS  Google Scholar 

  7. Lambert J, Jonlet F, Vanhooteghem O, et al. A non-IFNectious pyodermatitis: Pyoderma gangrenosum. Rev Med Liege 2001; 56: 106–11

    PubMed  CAS  Google Scholar 

  8. Guarneri C, Vaccaro M, Cannavo SP, et al. Erythematous-edematous-IFNiltrative plaque on the face: cutaneous angiolupoid leishmaniasis. Eur J Dermatol 2002; 12: 597–9

    PubMed  Google Scholar 

  9. Noblesse I, Beylot-Barry M, Doutre MS, et al. Cutaneous manifestations of rickettsiosis. Ann Dermatol Venereol 2002; 129: 1199–203

    PubMed  CAS  Google Scholar 

  10. Cnudde F, Gharakhanian S, Luboinski J, et al. Cutaneous local necrosis following interferon injections [letter]. Int J Dermatol 1991; 30: 147

    Article  PubMed  CAS  Google Scholar 

  11. Christian MM, Diven DG, Sanchez RL, et al. Injection site vasculitis in a patient receiving interferon alfa for chronic hepatitis C. J Am Acad Dermatol 1997; 37: 118–20

    Article  PubMed  CAS  Google Scholar 

  12. Yang CH, Chen CH, Chan HL. Skin necrosis following a recombinant interferon-beta-1b injection. Chang Gung Med J 2002; 25: 774–7

    PubMed  Google Scholar 

  13. Oh YB, Jun JB, Kim CK, et al. Mixed connective tissue disease associated with skin defects of livedoid vasculitis. Clin Rheumatol 2000; 19: 381–4

    Article  PubMed  CAS  Google Scholar 

  14. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981 Aug; 30(2): 239–45

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

We acknowledge financial support for this study from the Ministero della Salute (Programma di Ricerca Finalizzata anno 2002). The authors have provided no IFNormation on conflicts of interest directly relevant to the content of this study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to L. Gallelli.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gallelli, L., Guadagnino, V., Caroleo, B. et al. Bilateral Skin Ulceration after Injection of Pegylated Interferon-α-2b in a Patient with Chronic Hepatitis C. Clin. Drug Investig. 23, 615–619 (2003). https://doi.org/10.2165/00044011-200323090-00009

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00044011-200323090-00009

Keywords

Navigation